SCHEMBL12769102

SCHEMBL12769102

Pc1ccc2c(ccc3cc(P)ccc32)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.39
▸ HSD17B10 Q99714 3/20 0.39
▸ CYP1B1 Q16678 2/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ HPRT1 P00492 3/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ ERBB2 P04626 1/20 0.36
▸ FYN P06241 1/20 0.36
▸ MAOA P21397 1/20 0.36
▸ ACHE P22303 1/20 0.36
▸ AHR P35869 1/20 0.36
▸ CYP2A6 P11509 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ HPGD P15428 2/20 0.31
▸ CYP1A1 P04798 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20808993 0.87 ALDH1A1 (0.61) ALDH1A1HSD17B10CYP1B1HIF1AHPRT1
SCHEMBL12769101 0.85 CYP1A2 (0.52) ALDH1A1HSD17B10CYP1A2CYP2A6TDP1
SCHEMBL15318061 0.83 CYP2A6 (0.37) ALDH1A1HSD17B10CYP1A2CYP2A6TDP1
SCHEMBL12990955 0.82 ROCK1 (0.34) —
SCHEMBL15318065 0.78 ALDH1A1 (0.38) ALDH1A1HSD17B10HIF1ACYP1A2CYP2A6
SCHEMBL19618738 0.78 ALDH1A1 (0.41) ALDH1A1HSD17B10CYP1B1HIF1AHPRT1
SCHEMBL16901571 0.77 CYP1A1 (0.43) CYP1B1CYP1A2CYP1A1
SCHEMBL18388092 0.74 HTR2A (0.32) —
Bromide SCHEMBL9490218 0.73 ALDH1A1 (0.61) ALDH1A1HSD17B10CYP1B1HIF1AHPRT1
SCHEMBL3300856 0.73 CYP2A6 (0.48) ALDH1A1HSD17B10CYP1A2CYP2A6TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230134662-A1 LIQUID CRYSTAL LENS, HEAD MOUNTED DISPLAY AND POLARIZED SUNGLASSES Sharp Display Technology Corporation (JP) 2023-05-04 — — US disclosed
US-20210340330-A1 PHOTOALIGNING MATERIALS Rolic Technologies AG (CH) 2021-11-04 — — US disclosed
US-11053354-B2 Liquid crystal display device SHARP KABUSHIKI KAISHA (JP) 2021-07-06 — — US disclosed
US-10676671-B2 Method of reducing ODF mura in polymer stabilised liquid crystal displays MERCK PATENT GMBH (DE) 2020-06-09 — — US disclosed
EP-3322769-B1 METHOD OF REDUCING ODF MURA IN POLYMER STABILISED LIQUID CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2019-03-20 — — EP disclosed
US-10042207-B2 Liquid crystal display panel and liquid crystal display device SHARP KABUSHIKI KAISHA (JP) 2018-08-07 — — US disclosed
US-10031370-B2 Liquid crystal display device and method for manufacuring same SHARP KABUSHIKI KAISHA (JP) 2018-07-24 — — US disclosed
US-20180201837-A1 Method of Reducing ODF Mura in Polymer Stabilised Liquid Crystal Displays MERCK PATENT GMBH (DE) 2018-07-19 — — US disclosed
US-20180201837-A1 Method of Reducing ODF Mura in Polymer Stabilised Liquid Crystal Displays MERCK PATENT GMBH (DE) 2018-07-19 — — US disclosed
US-9995967-B2 Liquid crystal display device SHARP KABUSHIKI KAISHA (JP) 2018-06-12 — — US disclosed
US-9063380-B2 Method for manufacturing liquid crystal display device SHARP KABUSHIKI KAISHA (JP) 2015-06-23 — — US disclosed
US-20140360860-A1 METHOD FOR MANUFACTURING LIQUID CRYSTAL DISPLAY DEVICE SHARP KABUSHIKI KAISHA (JP) 2014-12-11 — — US disclosed
US-20140354930-A1 LIQUID CRYSTAL DISPLAY DEVICE SHARP KABUSHIKI KAISHA (JP) 2014-12-04 — — US disclosed
US-20140227929-A1 METHOD FOR MANUFACTURING LIQUID CRYSTAL DISPLAY DEVICE SHARP KABUSHIKI KAISHA (JP) 2014-08-14 — — US disclosed
US-20140213137-A1 METHOD FOR MANUFACTURING LIQUID CRYSTAL DISPLAY DEVICE SHARP KABUSHIKI KAISHA (JP) 2014-07-31 — — US disclosed
US-20140204322-A1 LIQUID CRYSTAL DISPLAY PANEL AND LIQUID CRYSTAL DISPLAY DEVICE SHARP KABUSHIKI KAISHA (JP) 2014-07-24 — — US disclosed
US-20140168589-A1 LIQUID CRYSTAL DISPLAY PANEL AND LIQUID CRYSTAL DISPLAY DEVICE SHARP KABUSHIKI KAISHA (JP) 2014-06-19 — — US disclosed
US-20130271713-A1 LIQUID CRYSTAL DISPLAY DEVICE AND METHOD FOR MANUFACTURING LIQUID CRYSTAL DISPLAY DEVICE SHARP KABUSHIKI KAISHA (JP) 2013-10-17 — — US disclosed
WO-2013050122-A1 PHOTOALIGNING MATERIALS ROLIC AG (CH) 2013-04-11 — — WO disclosed
US-20110051049-A1 LIQUID-CRYSTAL DISPLAY MERCK PATENT GESELLSCHAFT (DE) 2011-03-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110051049-A1 LIQUID-CRYSTAL DISPLAY VCL, LPXN, ACP3 ALDH1A1 3989/4885HSD17B10 2155/4885CYP1B1 4721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback